ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near Birmingham, AL, USA:

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis (MoveS-it)

A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts:Part A - first in human ...

Active, not recruiting
Multiple Sclerosis (MS)
Relapsing Remitting Multiple Sclerosis
Drug: Placebo
Drug: ANK-700

Phase 1

Anokion

Cullman, Alabama, United States of America and 14 other locations

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

Birmingham, Alabama, United States and 107 other locations

and adolescents 10 to 17 years of age with relapsing forms of multiple sclerosis (MS).Secondary Objective:* To assess the ...

Active, not recruiting
Multiple Sclerosis
Drug: Placebo
Drug: Teriflunomide

Phase 3

Genzyme
Genzyme

Cullman, Alabama, United States and 54 other locations

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Drug: Disease modifying treatment (DMT)
Drug: Ofatumumab

Phase 4

Novartis
Novartis

Birmingham, Alabama, United States and 33 other locations

A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Ofatumumab

Phase 3

Novartis
Novartis

Birmingham, Alabama, United States and 20 other locations

The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...

Enrolling
Multiple Sclerosis
Drug: CC-97540
Drug: Cyclophosphamide

Phase 1

Juno Therapeutics

Birmingham, Alabama, United States and 34 other locations

for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...

Active, not recruiting
Multiple Sclerosis
Drug: RPC-1063

Phase 3

Celgene
Celgene

Birmingham, Alabama, United States and 60 other locations

Primary Objective:To determine the long-term safety and tolerability of SAR442168 in RMS participantsSecondary Objective:To evaluate efficacy of SAR4...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Tolebrutinib

Phase 2

Sanofi
Sanofi

Cullman, Alabama, United States and 36 other locations

Locations recently updated

in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

Phase 3

Sanofi
Sanofi

Birmingham, Alabama, United States of America and 69 other locations

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...

Enrolling
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo

Phase 3

Sanofi
Sanofi

Birmingham, Alabama, United States of America and 53 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems